The global artificial urinary sphincter implantation device market was valued at $0.5 billion in 2023, and is projected to reach $1.1 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.
Report Code : A324368 | Pages : 280 | Category : Life Sciences
The U.S. radiopharmaceuticals market was valued at $3.0 billion in 2023, and is projected to reach $7.9 billion by 2033, growing at a CAGR of 10.2% from 2024 to 2033.
Report Code : A92815 | Pages : 90 | Category : Life Sciences
The Asia-Pacific radiopharmaceuticals market was valued at $1.9 billion in 2023, and is projected to reach $5.5 billion by 2033, growing at a CAGR of 11.4% from 2024 to 2033.
Report Code : A92824 | Pages : 110 | Category : Life Sciences
The North America radiopharmaceuticals market was valued at $3.2 billion in 2023, and is projected to reach $8.4 billion by 2033, growing at a CAGR of 10.2% from 2024 to 2033.
Report Code : A92814 | Pages : 110 | Category : Life Sciences
